|
1
|
Droszcz W: AstmaWydawnictwo Lekarskie
PZWL. Warszawa: 2007
|
|
2
|
Reddel HK and Levy ML: The GINA asthma
strategy report: What's new for primary care? Primary Care
Respiratory Med. 25:150502015. View Article : Google Scholar
|
|
3
|
Bel EH: Clinical phenotypes of asthma.
Curr Opin Pulm Med. 10:44–50. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moustakas A: Smad signalling network. J
Cell Sci. 115:3355–3356. 2002.PubMed/NCBI
|
|
5
|
Attisano L and Wrana JL: Signal
transduction by the TGF-beta superfamily. Science. 296:1646–1647.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Verrecchia F and Mauviel A: Transforming
growth factor-beta signaling through the Smad pathway: Role in
extracellular matrix gene expression and regulation. J Invest
Dermatol. 118:211–215. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Halwani R, Al-Muhsen S, Al-Jahdali H and
Hamid Q: Role of transforming growth factor-β in airway remodeling
in asthma. Am J Respir Cell Mol Biol. 44:127–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Letterio JJ and Roberts AB: TGF-beta: A
critical modulator of immune cell function. Clin Immunol
Immunopathol. 84:244–250. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Duvernelle C, Freund V and Frossard N:
Transforming growth factor-beta and its role in asthma. Pulm
Pharmacol Ther. 16:181–196. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mehta AA and Mahajan S: Role of cytokines
in pathophysiology of asthma. Iranian J Pharmacol Therapeut.
5:1–14. 2006.
|
|
11
|
McInnes IB and Gracie JA: Interleukin-15:
A new cytokine target for the treatment of inflammatory diseases.
Curr Opin Pharmacol. 4:392–397. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Anderson DM, Johnson L, Glaccum MB,
Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Kirstein MN,
Shapiro DN, Morris SW, et al: Chromosomal assignment and genomic
structure of II15. Genomics. 25:701–706. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Doherty TM, Seder RA and Sher A: Induction
and regulation of IL-15 expression in murine macrophages. J
Immunol. 156:735–741. 1996.PubMed/NCBI
|
|
14
|
Kennedy MK and Park LS: Characterization
of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin
Immunol. 16:134–143. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leclercq G, Debacker V, de Smedt M and
Plum J: Differential effects of interleukin-15 and interleukin-2 on
differentiation of bipotential T/natural killer progenitor cells. J
Exp Med. 184:325–336. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Armitage RJ, Macduff BM, Eisenman J,
Paxton R and Grabstein KH: IL-15 has stimulatory activity for the
induction of B cell proliferation and differentiation. J Immunol.
154:483–490. 1995.PubMed/NCBI
|
|
17
|
Kirman I, Vainer B and Nielsen OH:
Interleukin-15 and its role in chronic inflammatory diseases.
Inflamm Res. 47:285–289. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muro S, Taha R, Tsicopoulos A, Olivenstein
R, Tonnel AB, Christodoulopoulos P, Wallaert B and Hamid Q:
Expression of IL-15 in inflammatory pulmonary diseases. J Allergy
Clin Immunol. 108:970–975. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoontrakoon R, Chu HW, Gardai SJ, Wenzel
SE, McDonald P, Fadok VA, Henson PM and Bratton DL: Interleukin-15
inhibits spontaneous apoptosis in human eosinophils via autocrine
production of granulocyte macrophage-colony stimulating factor and
nuclear factor-kappaB activation. Am J Respir Cell Mol Biol.
26:404–412. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mori A, Suko M, Kaminuma O, Inoue S,
Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y,
et al: IL-15 promotes cytokine production of human T helper cells.
J Immunol. 156:2400–2405. 1996.PubMed/NCBI
|
|
21
|
Ishimitsu R, Nishimura H, Yajima T, Watase
T, Kawauchi H and Yoshikai Y: Overexpression of IL-15 in vivo
enhances Tc1 response, which inhibits allergic inflammation in a
murine model of asthma. J Immunol. 166:1991–2001. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Laza-Stanca V, Message SD, Edwards MR,
Parker HL, Zdrenghea MT, Kebadze T, Kon OM, Mallia P, Stanciu LA
and Johnston SL: The role of IL-15 deficiency in the pathogenesis
of virus-induced asthma exacerbations. PLoS Pathog. 7:e10021142011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Komai-Koma M, McKay A, Thomson L, McSharry
C, Chalmers GW, Liew FY and Thomson NC: Immuno-regulatory cytokines
in asthma: IL-15 and IL-13 in induced sputum. Clin Exp Allergy.
31:1441–1448. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Global Initiative for Asthma: Global
Strategy for Asthma Management and Prevention, Updated.
2017.http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/
|
|
25
|
Zalecenia Polskiego Towarzystwa
Ftyzjopneumonologicznego dotyczące wykonywania badań
spirometrycznych. PPneumonologia i Alergologia Polska. 74 (Suppl
1):2006.
|
|
26
|
Miller MR, Hankinson J, Brusasco V, Burgos
F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP,
Gustafsson P, et al: Standardisation of spirometry. Eur Respir J.
26:319–338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nathan RA, Sorkness CA, Kosinski M, Schatz
M, Li JT, Marcus P, Murray JJ and Pendergraft TB: Development of
the asthma control test: A survey for assessing asthma control. J
Allergy Clin Immunol. 113:59–65. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Borg GA: Psychophysical bases of perceived
exertion. Med Sci Sports Exerc. 14:377–381. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chomczynski P and Sacchi N: The
single-step method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction: Twenty-something years
on. Nat Protoc. 1:581–585. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Winer J, Jung CK, Shackel I and Williams
PM: Development and validation of real-time quantitative reverse
transcriptase-polymerase chain reaction for monitoring gene
expression in cardiac myocytes in vitro. Anal Biochem. 270:41–49.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Panek M, Pietras T, Szemraj J, Fabijan A
and Kuna P: Identification and association of TGFβ-1 expression in
patients with asthma in a Polish population-Lodz metropolitan area
study. Int J Biochem Mol Biol. 4:67–74. 2013.PubMed/NCBI
|
|
34
|
Koćwin M, Jonakowski M, Przemęcka M, Zioło
J, Panek M and Kuna P: The role of the TGF-SMAD signalling pathway
in the etiopathogenesis of severe asthma. Pneumonol Alergol Pol.
84:290–301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Panek M, Pietras T, Fabijan A, Zioło J,
Wieteska L, Małachowska B, Fendler W, Szemraj J and Kuna P:
Identification and association of the single nucleotide
polymorphisms, C-509T, C+466T and T+869C, of the TGF-β1 gene in
patients with asthma and their influence on the mRNA expression
level of TGF-β1. Int J Mol Med. 34:975–986. 2014.PubMed/NCBI
|
|
36
|
Panek M, Pietras T, Fabijan A, Zioło J,
Wieteska Ł, Małachowska B, Fendler W, Szemraj J and Kuna P: The
NR3C1 glucocorticoid receptor gene polymorphisms may modulate the
TGF-beta mRNA expression in asthma patients. Inflammation.
38:1479–1492. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Christensen U, Haagerup A, Binderup HG,
Vestbo J, Kruse TA and Børglum AD: Family based association
analysis of the IL2 and IL15 genes in allergic disorders. Eur J Hum
Genet. 14:227–235. 2005. View Article : Google Scholar
|
|
38
|
Pinto LA, Depner M, Steudemann L, Klopp N,
Illig T, von Mutius E and Kabesch M: IL15 gene variants are not
associated with asthma and atopy. Allergy. 64:643–646. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bierbaum S, Nickel R, Zitnik S, Ahlert I,
Lau S, Deichmann KA, Wahn U and Heinzmann A: Confirmation of
association of IL-15 with pediatric asthma and comparison of
different controls. Allergy. 61:576–580. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jachnik M, Szczepankiewicz A and
Bręborowicz A: Influence of IL15 gene polymorphism on the course of
bronchial asthma in children. Alergia Astma Immunologia.
16:200–204. 2011.
|
|
41
|
Sanjabi S, Mosaheb MM and Flavell RA:
Opposing effects of TGF-beta and IL-15 cytokines control the number
of short-lived effector CD8+ T cells. Immunity. 31:131–144. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Benahmed M, Meresse B, Arnulf B, Barbe U,
Mention JJ, Verkarre V, Allez M, Cellier C, Hermine O and
Cerf-Bensussan N: Inhibition of TGF-beta signaling by IL-15: A new
role for IL-15 in the loss of immune homeostasis in celiac disease.
Gastroenterology. 132:994–1008. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zdrenghea MT, Telcian AG, Laza-Stanca V,
Bellettato CM, Edwards MR, Nikonova A, Khaitov MR, Azimi N, Groh V,
Mallia P, et al: RSV infection modulates IL-15 production and MICA
levels in respiratory epithelial cells. Eur Respir J. 39:712–720.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Azimi N, Shiramizu KM, Tagaya Y, Mariner J
and Waldmann TA: Viral activation of interleukin-15 (IL-15):
Characterization of a virus-inducible element in the IL-15 promoter
region. J Virol. 74:7338–7348. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Esen M, Forster J, Ajua A, Spänkuch I,
Paparoupa M, Mordmüller B and Kremsner PG: Effect of IL-15 on IgG
versus IgE antibody-secreting cells in vitro. J Immunol Methods.
375:7–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Roth M, Zhao F, Zhong J, Lardinois D and
Tamm M: Serum IgE induced airway smooth muscle cell remodeling is
independent of allergens and is prevented by omalizumab. PLoS One.
10:e01365492015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Domingo C: Omalizumab for severe asthma:
Efficacy beyond the atopic patient? Drugs. 74:521–533. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Menzella F, Piro R, Facciolongo N,
Castagnetti C, Simonazzi A and Zucchi L: Long-term benefits of
omalizumab in a patient with severe non-allergic asthma. Allergy
Asthma Clin Immunol. 7:92011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kupryś-Lipińska I and Kuna P: Omalizumab,
recombinant humanized monoclonal antibody anti-IgE-new fields of
studies on the therapeutic indications. Pneumonol Alergol Pol.
77:43–51. 2009.(In Polish). PubMed/NCBI
|
|
50
|
Yan L, Xiao-Ling S, Zheng-Yan C, Guo-Ping
L, Sen Z and Zhuang C: HSP70/CD80 DNA vaccine inhibits airway
remodeling by regulating the transcription factors T-bet and GATA-3
in a murine model of chronic asthma. Archives Med Sci. 9:906–915.
2013. View Article : Google Scholar
|
|
51
|
Moustaki A, Argyropoulos KV, Baxevanis CN,
Papamichail M and Perez SA: Effect of the simultaneous
administration of glucocorticoids and IL-15 on human NK cell
phenotype, proliferation and function. Cancer Immunol Immunother.
60:1683–1695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wiegers GJ and Reul JM: Induction of
cytokine receptors by glucocorticoids: Functional and pathological
significance. Trends Pharmacol Sci. 19:317–321. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ring AM, Lin JX, Feng D, Mitra S, Rickert
M, Bowman GR, Pande VS, Li P, Moraga I, Spolski R, et al:
Mechanistic and structural insight into the functional dichotomy
between IL-2 and IL-15. Nat Immunol. 13:1187–1195. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sher ER, Leung DY, Surs W, Kam JC, Zieg G,
Kamada AK and Szefler SJ: Steroid-resistant asthma. Cellular
mechanisms contributing to inadequate response to glucocorticoid
therapy. J Clin Invest. 93:33–39. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sugiura H, Kawabata H, Ichikawa T, Koarai
A, Yanagisawa S, Kikuchi T, Minakata Y, Matsunaga K, Nakanishi M,
Hirano T, et al: Inhibitory effects of theophylline on the
peroxynitrite-augmented release of matrix metalloproteinases by
lung fibroblasts. Am J Physiol Lung Cell Mol Physiol.
302:L764–L774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Layseca-Espinosa E, Sanchez-Madrid F and
Gonzalez-Amaro R: Phosphodiesterase inhibitors as immunomodulatory
drugs. Inmunología. 22:39–52. 2003.
|
|
57
|
Cohen Y, Eini H, Chaimovitz C and
Douvdevani A: 53: Inhibition of interleukin-15 dependent cytotoxic
T-cell proliferation by the action of adenosine on dendritic cell.
Cytokine. 63:255–256. 2013. View Article : Google Scholar
|
|
58
|
Zdrenghea MT: Could interleukin-15
potentiate histone deacetylase inhibitor effects in haematological
malignancy? Med Hypotheses. 81:311–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
